Tuesday 12 May 2020

German medical technology manufacturer Drägerwerk turns to the equity capital markets to finance increase in Covid-19 ventilator production.


Drägerwerk AG & Co KGaA, a German manufacturer of medical technology (e.g. ventilators, anaesthesia devices, patient monitors, etc.) as well as safety technology products (e.g. face masks), has issued one million new preference shares in the equity capital markets to raise €76.5 million. Proceeds from the capital increase will be used to support the scaling up of production during the Covid-19 pandemic and to strengthen the equity base and liquidity.

The shares were offered in a private placement to institutional investors and the transaction was multiple times oversubscribed, highlighting the role investors are playing in supporting corporates during the coronavirus crisis. BNP Paribas Global Banking teams supported Drägerwerk throughout the book-building process, acting as joint global coordinator. 
" The capital increase will be used to support the scaling up of production during the Covid-19 pandemic and to strengthen the equity base and liquidity. "

Given the company's vital role in producing and maintaining critical healthcare infrastructure, Drägerwerk has seen a 177% increase of orders (net of currency effects) in its medical division in Q1 2020 vs Q1 2019. In light of the high order intake resulting from the Covid-19 pandemic, accessing the equity markets for fresh capital has been an important financial lever to address the current situation.

Drägerwerk's state-of-the-art factory in Lübeck, combined with flexible working hours and innovative labour organisation models, have allowed the firm to significantly increase output of ventilators.

According to the World Health Organisation, there are over 3.5 million confirmed coronavirus cases globally, as of 5 May 2020.






 

4
3
3
3
0
 
 

Give us your feedback

Please validate CAPTCHA.

RELATED ARTICLES
euromoney-recognises-bnp-paribas-investment-banking-expertise

The bank has been recognised for supporting clients throughout the Covid-19 crisis. Our experts explain their adapted approach and look ahead to the future.

-ole-spain-investors-day-goes-global
120 investors, 40 leading companies, 700 meetings: how Spain Investors Day became the No...
120 investors, 40 leading companies, 700 meetings: how Spain Investors Day became the No. 1 equities forum in Spain.
exane-bnp-paribas-tops-2020-research-poll-institutional-investor
Exane BNP Paribas ranked No. 1 in all headline equity categories in Institutional Investor's 2020 All...
Exane BNP Paribas ranked No. 1 in all headline equity categories in Institutional Investor's 2020 All-Europe Research Survey...
the-us-fiscal-and-monetary-response-to-covid-19-next-steps
At a virtual Markets360 Unplugged event, industry leaders shared insights into the US macro outlook and...
At a virtual Markets360 Unplugged event, industry leaders shared insights into the US macro outlook and how the Federal Reserve...
the-next-stage-of-the-equity-recovery
At the virtual Markets360 Unplugged event, market experts discussed the power of discount factors and...
At the virtual Markets360 Unplugged event, market experts discussed the power of discount factors and the outlook for developed...
close
{POPUP_CONTENT}